Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-24T23:20:27.371Z Has data issue: false hasContentIssue false

56 - Treatment of Paroxysmal Dystonia

from Section VII - Pharmacotherapy for Dystonia

Published online by Cambridge University Press:  31 May 2018

By
Roberto Erro ,
Bettina Balint  and
Kailash P. Bhatia
Edited by
Dirk Dressler ,
Eckart Altenmüller  and
Joachim K. Krauss
Dirk Dressler
Affiliation:
Hannover Medical School
Eckart Altenmüller
Affiliation:
Hochschule für Musik, Theater und Medien, Hannover
Joachim K. Krauss
Affiliation:
Hannover Medical School
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Treatment of Dystonia , pp. 292 - 296
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baschieri, F, Batla, A, Erro, R, Ganos, C, Cordivari, C, Bhatia, KP. 2014. Paroxysmal exercise-induced dystonia due to GLUT1 mutation can be responsive to levodopa: a case report. Journal of Neurology 261(3):615–616.CrossRefGoogle ScholarPubMed
Brockmann, K, Dumitrescu, AM, Best, TT, Hanefeld, F, Refetoff, S. 2005. X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene. Journal of Neurology 252(6):663–666.Google Scholar
Bruno, MK, Hallett, M, Gwinn-Hardy, K, Sorensen, B, Considine, E, Tucker, S, et al. 2004. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology 63(12):2280–2287.CrossRefGoogle ScholarPubMed
Bruno, MK, Lee, HY, Auburger, GW, Friedman, A, Nielsen, JE, Lang, AE, et al. 2007. Genotype–phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 68(21):1782–1789.CrossRefGoogle ScholarPubMed
Erro, R, Sheerin, UM, Bhatia, KP. 2014a. Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. Movement Disorders: Official Journal of the Movement Disorder Society 29(9):1108–1116.Google Scholar
Erro, R, Stamelou, M, Ganos, C, Skorvanek, M, Han, V, Batla, A, et al. 2014b. The clinical syndrome of paroxysmal exercise-induced dystonia: diagnostic outcomes and an algorithm. Movement Disorders: Clinical Practice 1(1):57–61.Google Scholar
Guimaraes, J, Vale Santos, J. 2000. Paroxysmal dystonia induced by exercise and acetazolamide. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 7(2):237–240.CrossRefGoogle ScholarPubMed
Lee, G, Huang, Y, Washington, JM, Briggs, NW, Zuo, Z. 2005. Carbamazepine enhances the activity of glutamate transporter type 3 via phosphatidylinositol 3-kinase. Epilepsy Research 66(1–3):145–153.CrossRefGoogle ScholarPubMed
Leen, WG, Mewasingh, L, Verbeek, MM, Kamsteeg, EJ, van de Warrenburg, BP, Willemsen, MA. 2013. Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet. Movement Disorders: Official Journal of the Movement Disorder Society 28(10):1439–1442.CrossRefGoogle ScholarPubMed
Li, HF, Chen, WJ, Ni, W, Wang, KY, Liu, GL, Wang, N, et al. 2013. PRRT2 mutation correlated with phenotype of paroxysmal kinesigenic dyskinesia and drug response. Neurology 80(16):1534–1535.CrossRefGoogle ScholarPubMed
Li, M, Niu, F, Zhu, X, Wu, X, Shen, N, Peng, X, et al. 2015. PRRT2 mutant leads to dysfunction of glutamate signaling. International Journal of Molecular Sciences 16(5):9134–9151.Google Scholar
Mathew, T, Aroor, S, Nadig, R, Sarma, GR. 2012. Lacosamide in paroxysmal kinesigenic dyskinesia. Movement Disorders: Official Journal of the Movement Disorder Society 27(6):801–802.CrossRefGoogle ScholarPubMed
Mencacci, NE, Erro, R, Wiethoff, S, Hersheson, J, Ryten, M, Balint, B, et al. 2015. ADCY5 mutations are another cause of benign hereditary chorea. Neurology 85(1):80–88.CrossRefGoogle ScholarPubMed
Mink, JW. 2015. Treatment of paroxysmal dyskinesias in children. Current Treatment Options in Neurology 17(6):350.CrossRefGoogle ScholarPubMed
Neville, BG, Ninan, M. 2007. The treatment and management of alternating hemiplegia of childhood. Developmental Medicine and Child Neurology 49(10):777–780.Google Scholar
Ramm-Pettersen, A, Nakken, KO, Skogseid, IM, Randby, H, Skei, EB, Bindoff, LA, et al. 2013. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Developmental Medicine and Child Neurology 55(5):440–447.Google Scholar
Shen, Y, Ge, WP, Li, Y, Hirano, A, Lee, HY, Rohlmann, A, et al. 2015. Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis. Proceedings of the National Academy of Sciences of the United States of America 112(10):2935–2941.CrossRefGoogle ScholarPubMed
Suls, A, Dedeken, P, Goffin, K, Van Esch, H, Dupont, P, Cassiman, D, et al. 2008. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain: A Journal of Neurology 131(Pt 7):1831–1844.CrossRefGoogle ScholarPubMed
Verge, CF, Konrad, D, Cohen, M, Di Cosmo, C, Dumitrescu, AM, Marcinkowski, T, et al. 2012. Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. The Journal of Clinical Endocrinology and Metabolism 97(12):4515–4523.Google Scholar
Yang, Y, Su, Y, Guo, Y, Ding, Y, Xu, S, Jiang, Y, et al. 2012. Oxcarbazepine versus carbamazepine in the treatment of paroxysmal kinesigenic dyskinesia. The International Journal of Neuroscience 122(12):719–722.CrossRefGoogle ScholarPubMed
Yokoyama, CT, Myers, SJ, Fu, J, Mockus, SM, Scheuer, T, Catterall, WA. 2005. Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interaction site. Molecular and Cellular Neurosciences 28(1):1–17.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×